Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why do Lannett and Elite need to spend the money for a press release of a launch when they both , in prior press release said launch was immenent. Quarterly reports are very soon and an update will be given.
Cash Flow Positive....Buy Out Imminent
Would be nice. Maybe after approvals. I noticed that Naz didnt get on the soap box about uplisting to the Nasdaq as he has in prior presentations. Almosted hinted that now that the j series shares can be satisfied with a positive share increase , ELTP is a clean buyout or partner. I'm thinking something is on the table and is continjent on the immenent approvals.
As an addendum to the summary, I would be remiss in not acknowledging that my interest in LCI was born of an investment in a small company that is now an LCI business partner. As noted in the discussion of Threat Three in the article, that company is Elite Pharma (OTCQB:ELTP), a small OTC company that is extremely undervalued and, likely, worthy of an article for its a major turnaround. But for now, it suffices to say Elite has multiple drugs being commercialized by LCI, including generic Adderall. Moreover, Elite and its privately held partner SunGen Pharma are expecting FDA approval later this month for an extended-release CNS ANDA that, according to IQVIA data, has an annual market of $1.6B and will be commercialized by Lannett.
Indeed, this shows how astutely LCI is building its business, with key partnerships and targeted internal development. Without question, this should translate well into future revenue growth for the company. While growth does not cure all ills or ameliorate all threats, it does rhyme.
https://seekingalpha.com/article/4311033-lannett-building-success-one-step-time
My interpretation is up listing to the Nasdaq requires us to have increased revenues. The re shuffling of products and the New Date for review in Dec has stretched the timeline. Had the opiate world not change along with the FDA, we would already be in dollar land . Remember , Naz does not want a reverse split. I predict by the 3rd quarter 2020 the timeline will be less than a year.
Some interesting data. Not since Oct 14"s record low trading volume of 44k shares traded do we now have a 50% lower low volume of 18K on Oct 24. The last closest day was June 13 @ 59k which was followed by NINE days of trading volume of over a million and more! went back to Oct 2018.
Somethings up. I'm betting its the near term stock price.
The Internal Control issues mentioned in the 10K spoke of our CFO trying to handle the new work load himself. He needs to hire full time talent to assist him with all these deals and stuff.
I call those growing pains that was identified in a timely manner as the safeguard audits were intended to do.
No harm....No foul
Only one time did a CC benefit the stock holders....
2014 February
"Nothing can stop us !!"
Went from .12 to .97 in 3 days....
My biggest fear is Naz's ego. I'm done financing his dreams. Powers in charge at the FDA are too entrenched and can stop us and at minimal continue to slow us down. We need a strong arm on our side with deep pockets if he wants to continue this aggressive R&D path. I like this course but we see now that the revenue isn't keeping up .
I'm thinking that these are the interpretations of the legal wording. They do also ask for additional proposals to be submitted to be reviewed and voted on.
Its in the 10K . About half way through. along with the going concern.
Shareholders meeting on Sept 25 (or so ) will vote on two positions....
1. Reverse split and re-issuance of some shares so we may reep the full benefits of all the hard work to date...or 2. accept a low ball bid that Naz has in hand and merge.
I'm voting for the immediate buyout. Alone we can be stopped!
Shareholders meeting on or about September 25, 2019 to discuss increasing share count or another proposed plan to get through this. Proposals are to be submitted.
I'm thinking with all the new launches and new revenue starting , we have enough to keep the doors open as is , but not to pump out ANDA's and especially not to get Sequestox going again.
We sold 22 million shares for 2.2 million cause of the suppressed stock price. Man o man.
Cant wait till Monday
15 minutes is plenty of time. Actually the statement itself is only a few minutes or so. This is just a taste of the future. As is the other entries. Very simple... encouraging results....future studies.....off script label sales jump and Revenue Increases. Bingo !
NEXT !!!
This was the first confrence call I can remember where Nasarat didn't mention the Nasdaq or Dollar Land. Hmmmmm ....maybe the pending merger and new company will take care of both.
100 shares traded to drop it to .083. WTF , do they wear ski masks at the OTC.
Monday Release ..... not on a Friday........Yea baby....here we go !!!
Now they're back for 314 shares , to move it to .083
Let's see.... 30 shares at .0866 = $2.60. Again , the cost of the trade is more than the investment. Man o man something must be up with this type of desperation
30 shares traded.......are you F..... kidding me.
Yes.... the upcoming Quarterly will show a significant increase in revenue and future guidance will be positive . This will create the multi million trade day and our first double IMO.
The issue here is were only trading among Believers and Manipulators. New money is on the sideline. The real catalyst is the positive Isradipine study which is where new money will enter and help with this huge Float. I agree that this is a concern , hence the risk. IMO this will be worked out with the increase in revenues which will allow ELTP more options to change.
aka....dollar land and more in 2019.
I don't understand the science all that well , but I do see a unique situation where ELTP may ( IMO ..will ) be one of those few companies that will move up from the bowels of the OTC. A small percent of my portfolio gamble's on OTC all the time along with scratchies and keno.
My point today is that the bet is on what can or will materialize in the form of assets to increase value. At .09 cents , other comparable companies are in bad shape financially and have no future. They either hit a wall or can't adapt to change and become irrelevant. Not ELTP. At minimal this is a short term double alone. The .09 cent base has been a gift allowing me to purchase many 10K blocks to double my holdings in a years time.
I must admit that I have not witnessed such a blatantly targeted manipulation of a Security as I have with ELTP. Not to mention the daily interest in the chat rooms is , Of the Chart. I mean hourly monitoring going on by some for years ( yes , by me too). Besides the fact that many catalyst are coming to fruition now , the fact that the largest share holder of common stock in ELTP is the CEO himself. 3 million worth purchased on the open market. Not to mention BOD and Officers also own shares. This is the biggest tell !! Smart educated people choosing to serve and believing in the company enough to take risk. You don't see this in many other securities in the OTC world. The ones that do usually make it out.
Now add in the growing pipeline and new hires, partners, facility upgrades , filings ..... no wonder some people may feel threatened by ELTP becoming a competitor .
The newest catalyst that is the defining moment for this company is the growing contempt for the big pharma and their manipulation of competition and product. Even the Government has had enough and is intervening to promote Generics and cost savings for the American People.
Fellow ELTP Longs..... Our moment is here. With in 2 weeks our first double up in share price will happen. We're very cheap at .09 and should hold .20-.30 . My only concern is the desperation of this manipulator and how they may buy the profit shares we sell into the pop , only to start their games again. I hope that I'm not the only one noticing and some discrete action is taken by the OTC or SEC , if it hasn't already.
That is a true statement. Lol , thank you for the correction. Man.... $9 ....cost me $6.50 just for the trade. So blatant, yet been going on for years. NASDAQ!
110 shares .....roughly $90. Hmmm.
NO doubt somethings up. 30 min in to trading and not one share traded. My guess is the increase in revenue and a potential positive news with the Parkinson Trials has no legitimate trader selling with the potential of a revisit to our 52 week high and beyond. Cash flow positive! Record earnings ! Increase demand for products !
This is text book success of a Business model. No denial except noise from competitors.
Last year it was on February 28.
I think those assets are locked up . Either way , this reporting quarter should be interesting.
The calm before the buyout !! Unusually long period of silence. They either are broke or in quite mode. Little suspicious seeing their cash flow is dwindling. I'm thinking their saving money from fluff pieces that do nothing.
Elite Labs is a Subsidiary of Elite Pharma.
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=5864414
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process
Elite Labs Inc got a Manufacturing Approval (CMC) on 12/27/2018 for Trimipramine Maleate
Now is it a true statement that Dr. Aqeel A. Fatmi will also be paid in shares ?
50k shares traded at the halfway mark. Hmmmm Nothing for 40 minutes. Must be a free lunch somewhere.
I love the part of the 8-K filed on Dec 19 , "PRE-APPROVAL INSPECTION" !
Oh man, the Calm before the Storm.
REMOXY-ER byPzifer has been given 2 letters from the FDA. One to call them out on putting on their web site that Remoxy-ER was approved. Two was the CRL. F***them A**holes at Pzifer. There was an article over the weekend on Yahoo about Pzifer's influence over the FDA and States with regards to their drugs and their Lobbyist who spend huge amounts of money and time influencing legislation. This has finally gone right for the consumer
The shares sold today were from Epic's 2.8 million they said on the Form 4 form. I believe a 5 million payment is due to Elite.
YA, it sounds right. Pun intended!
Nothing good will come of this other than YA gets some of his money back. We , the shareholders, embarrassed him and now he is having the last laugh! I say sell your shares now, let LM & the BOD get canned and watch where those patent's land! Enough with this horse S**t. Their playing us. This is a "Milk it for all it's worth" company that is too far in debt to see the light of day!
This is not the end of the tunnel; it's an on-coming train!
Take your money now!!!!
Listen All; They hate the share holder's. We embarrassed them with the negative vote. They are only spending time to re-group before they drop the BOMB! Time is necessary to defend an ultimatum ! Unload and watch where they land; then back the truck up!
The 8k sounds to me like the "Head's of State" are putting more "Skin in the Game"! I have never seen such an insider investment to a cause. They are "Tipping their Cards" to us and we are fools not to acknowledge by loading up and HOLDING! Make the MM's Pay! Enough with the petty BS. This is gonna happen and happen big. I'm buying, on Monday, another 100,000 shares. I will not sell my first share under a $1.